{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:10:32Z","timestamp":1790878232431,"version":"4.1.0"},"reference-count":237,"publisher":"Elsevier","isbn-type":[{"value":"9780443294143","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["NO.BT\/HRD\/35\/02\/2006"],"award-info":[{"award-number":["NO.BT\/HRD\/35\/02\/2006"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["CRG\/2021\/003805"],"award-info":[{"award-number":["CRG\/2021\/003805"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apcsb.2025.08.012","type":"book-chapter","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:09:08Z","timestamp":1756933748000},"page":"135-177","source":"Crossref","is-referenced-by-count":2,"title":["Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.apcsb.2025.08.012_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.742408","article-title":"Alzheimer\u2019s disease: An update and insights into pathophysiology","volume":"14","author":"Abubakar","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1731-2","article-title":"Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson\u2019s disease","volume":"17","author":"Ahn","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/hmg\/6.5.695","article-title":"The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: Is there correlation between genotype and phenotype?","volume":"6","author":"Andresen","year":"1997","journal-title":"Human Molecular Genetics"},{"issue":"4096","key":"10.1016\/bs.apcsb.2025.08.012_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.181.4096.223","article-title":"Principles that govern the folding of protein chains","volume":"181","author":"Anfinsen","year":"1973","journal-title":"Science (New York, NY)"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/jnp.2007.19.4.428","article-title":"Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? A meta-analysis of the past 10 years","volume":"19","author":"Appleby","year":"2007","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib6","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington\u2019s disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"elife"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.012_bib7","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1080\/09593985.2023.2210218","article-title":"Examining the effects of amplitude-based training as a component of the plan of care in an individual with olivopontocerebellar atrophy","volume":"40","author":"Babcock","year":"2024","journal-title":"Physiotherapy Theory and Practice"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington\u2019s disease 6 years after surgery: A long-term follow-up study","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.641372","article-title":"Amyloid-like aggregation in diseases and biomaterials: Osmosis of structural information","volume":"9","author":"Balasco","year":"2021","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"6294","key":"10.1016\/bs.apcsb.2025.08.012_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/science.aac4354","article-title":"In vivo aspects of protein folding and quality control","volume":"353","author":"Balchin","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib11","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nature Medicine"},{"issue":"5521","key":"10.1016\/bs.apcsb.2025.08.012_bib12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science (New York, NY)"},{"issue":"33","key":"10.1016\/bs.apcsb.2025.08.012_bib13","doi-asserted-by":"crossref","first-page":"23633","DOI":"10.1074\/jbc.C113.481945","article-title":"Heat shock response activation exacerbates inclusion body formation in a cellular model of huntington disease","volume":"288","author":"Bersuker","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s13311-013-0192-7","article-title":"Natural compounds May open new routes to treatment of amyloid diseases","volume":"10","author":"Bieschke","year":"2013","journal-title":"Neurotherapeutics: the journal of the American Society for Experimental Neuro Therapeutics"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib15","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/bmt.2008.275","article-title":"Metachromatic leukodystrophy: An overview of current and prospective treatments","volume":"42","author":"Biffi","year":"2008","journal-title":"Bone Marrow Transplantation"},{"issue":"45","key":"10.1016\/bs.apcsb.2025.08.012_bib16","doi-asserted-by":"crossref","first-page":"16926","DOI":"10.1021\/ja406197f","article-title":"Ion mobility spectrometry reveals the mechanism of amyloid formation of A\u03b2(25-35) and its modulation by inhibitors at the molecular level: Epigallocatechin gallate and scyllo-inositol","volume":"135","author":"Bleiholder","year":"2013","journal-title":"Journal of the American Chemical Society"},{"issue":"21","key":"10.1016\/bs.apcsb.2025.08.012_bib17","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","article-title":"Abeta targets of the biosimilar antibodies of bapineuzumab, crenezumab, solanezumab in comparison to an antibody against N-truncated abeta in sporadic alzheimer disease cases and mouse models","volume":"130","author":"Bouter","year":"2015","journal-title":"Acta Neuropathologica"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.012_bib20","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/j.jmb.2015.05.010","article-title":"The chemical biology of molecular chaperones\u2014implications for modulation of proteostasis","volume":"427","author":"Brandvold","year":"2015","journal-title":"Journal of Molecular Biology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.celrep.2014.09.042","article-title":"A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease","volume":"9","author":"Brehme","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-014-1299-6","article-title":"TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord","volume":"128","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.23937","article-title":"Stages of pTDP\u201043 pathology in amyotrophic lateral sclerosis","volume":"74","author":"Brettschneider","year":"2013","journal-title":"Annals of Neurology"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.012_bib24","doi-asserted-by":"crossref","first-page":"10284","DOI":"10.1074\/jbc.270.17.10284","article-title":"Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly, and stability of MCAD enzyme","volume":"270","author":"Bross","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annual Review of Neuroscience"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"30","key":"10.1016\/bs.apcsb.2025.08.012_bib27","doi-asserted-by":"crossref","first-page":"31374","DOI":"10.1074\/jbc.M400348200","article-title":"Prefibrillar amyloid protein aggregates share common features of cytotoxicity","volume":"279","author":"Bucciantini","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"6880","key":"10.1016\/bs.apcsb.2025.08.012_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"Bucciantini","year":"2002","journal-title":"Nature"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131985","article-title":"In vivo profiling reveals a competent heat shock response in adult neurons: Implications for neurodegenerative disorders","volume":"10","author":"Carnemolla","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.26.010302.081142","article-title":"Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders","volume":"26","author":"Caughey","year":"2003","journal-title":"Annual Review of Neuroscience"},{"issue":"Pt 15","key":"10.1016\/bs.apcsb.2025.08.012_bib31","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1242\/jcs.02473","article-title":"Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates","volume":"118","author":"Cecchi","year":"2005","journal-title":"Journal of Cell Science"},{"issue":"5-6","key":"10.1016\/bs.apcsb.2025.08.012_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: A critical review","volume":"10","author":"Chi\u00f2","year":"2009","journal-title":"Amyotrophic Lateral Sclerosis: Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nchembio.131","article-title":"Amyloid formation by globular proteins under native conditions","volume":"5","author":"Chiti","year":"2009","journal-title":"Nature Chemical Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/nen.0b013e318156a3d7","article-title":"Location, location, location: Altered transcription factor trafficking in neurodegeneration","volume":"66","author":"Chu","year":"2007","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib19","unstructured":"Company ELa. Lilly\u2019s Kisunla\u2122 (donanemab-azbt) approved by the FDA for the treatment of early symptomatic Alzheimer\u2019s disease 2024. Available from: https:\/\/investor.lilly.com\/news-releases\/news-release-details\/lillys-kisunlatm-donanemab-azbt-approved-fda-treatment-early."},{"key":"10.1016\/bs.apcsb.2025.08.012_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.prdoa.2019.08.005","article-title":"Corticobasal degeneration and corticobasal syndrome: A review","volume":"1","author":"Constantinides","year":"2019","journal-title":"Clinical Parkinsonism & Related Disorders"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009423","article-title":"Disruption of protein quality control in Parkinson\u2019s disease","volume":"2","author":"Cook","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6075","key":"10.1016\/bs.apcsb.2025.08.012_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","article-title":"ApoE-directed therapeutics rapidly clear \u03b2-amyloid and reverse deficits in AD mouse models","volume":"335","author":"Cramer","year":"2012","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib39","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1038\/srep09649","article-title":"Molecular basis for mid-region amyloid-\u03b2 capture by leading Alzheimer\u2019s disease immunotherapies","volume":"5","author":"Crespi","year":"2015","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib40","article-title":"Alzheimer\u2019s disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.08.012_bib41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer\u2019s disease: Novel targets and investigational drugs for disease modification","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Cz\u0142onkowska","year":"2018","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","article-title":"Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease","volume":"12","author":"D\u2018Errico","year":"2020","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2018.00075","article-title":"Precise excision of the CAG tract from the huntingtin gene by Cas9 nickases","volume":"12","author":"Dabrowska","year":"2018","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fnmol.2014.00070","article-title":"The ubiquitin-proteasome system in neurodegenerative diseases: Precipitating factor, yet part of the solution","volume":"7","author":"Dantuma","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib46","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/brain\/awac428","article-title":"Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates","volume":"146","author":"Darricau","year":"2023","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib47","first-page":"16","article-title":"Clearance of amyloid-\u03b2 peptide across the blood-brain barrier: Implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.012_bib68","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.bbapap.2014.08.016","article-title":"Antibodies and protein misfolding: From structural research tools to therapeutic strategies","volume":"1844","author":"De Genst","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.012_bib48","first-page":"504","article-title":"Parkinson\u2019s disease and its management: part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"Pharmacy and Therapeutics"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib128","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s12311-023-01600-x","article-title":"Epidemiology of spinocerebellar ataxias in Europe","volume":"23","author":"De Mattei","year":"2024","journal-title":"The Cerebellum"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib149","article-title":"Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays","volume":"417","author":"de Oliveira Scott","year":"2020","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib49","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.cell.2012.09.038","article-title":"Operational plasticity enables hsp104 to disaggregate diverse amyloid and nonamyloid clients","volume":"151","author":"DeSantis","year":"2012","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrg1018","article-title":"Dying for a cause: Invertebrate genetics takes on human neurodegeneration","volume":"4","author":"Driscoll","year":"2003","journal-title":"Nature Reviews Genetics"},{"issue":"23","key":"10.1016\/bs.apcsb.2025.08.012_bib51","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1101\/gad.1673408","article-title":"Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity","volume":"22","author":"Duennwald","year":"2008","journal-title":"Genes & Development"},{"issue":"41","key":"10.1016\/bs.apcsb.2025.08.012_bib52","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1523\/JNEUROSCI.1560-11.2011","article-title":"Distinct roles in vivo for the ubiquitin\u2013proteasome system and the autophagy\u2013lysosomal pathway in the degradation of \u03b1-uclein","volume":"31","author":"Ebrahimi-Fakhari","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-1-79","article-title":"Molecular chaperones and protein folding as therapeutic targets in Parkinson\u2019s disease and other ucleinopathies","volume":"1","author":"Ebrahimi-Fakhari","year":"2013","journal-title":"Acta Neuropathologica Communications"},{"issue":"6880","key":"10.1016\/bs.apcsb.2025.08.012_bib54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/416483a","article-title":"Medicine: Danger--misfolding proteins","volume":"416","author":"Ellis","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib56","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","article-title":"Safety and efficacy of continuous subcutaneous levodopa\u2013carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): A phase 3, randomised, double-blind, double-dummy, multicentre trial","volume":"23","author":"Espay","year":"2024","journal-title":"The Lancet Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.irn.2019.10.004","article-title":"Multiple system atrophy","volume":"149","author":"Fanciulli","year":"2019","journal-title":"International Review of Neurobiology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib59","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1038\/s41598-017-04256-w","article-title":"The stress response factor daf-16\/FOXO is required for multiple compound families to prolong the function of neurons with Huntington\u2019s disease","volume":"7","author":"Farina","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110234","article-title":"The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway","volume":"127","author":"Farkhondeh","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-015-0226-y","article-title":"Spread of pathology in amyotrophic lateral sclerosis: Assessment of phosphorylated TDP-43 along axonal pathways","volume":"3","author":"Fatima","year":"2015","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-uclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"25","key":"10.1016\/bs.apcsb.2025.08.012_bib63","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2174\/1568026616666160413140741","article-title":"Neurodegeneration and the heat shock protein 70 machinery: Implications for therapeutic development","volume":"16","author":"Fontaine","year":"2016","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of alzheimer disease: The amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib65","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-015-1484-2","article-title":"Comparing the efficacy and neuroinflammatory potential of three -abeta antibodies","volume":"130","author":"Fuller","year":"2015","journal-title":"Acta Neuropathologica"},{"issue":"38","key":"10.1016\/bs.apcsb.2025.08.012_bib66","doi-asserted-by":"crossref","first-page":"29737","DOI":"10.1074\/jbc.M003231200","article-title":"Expression analysis of phenylketonuria mutations. Effect on folding and stability of the phenylalanine hydroxylase protein","volume":"275","author":"G\u00e1mez","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib67","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/19336896.2015.1011887","article-title":"Regulating extracellular proteostasis capacity through the unfolded protein response","volume":"9","author":"Genereux","year":"2015","journal-title":"Prion"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archneur.65.5.636","article-title":"Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis","volume":"65","author":"Geser","year":"2008","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-017-0298-7","article-title":"Propagation of tau aggregates","volume":"10","author":"Goedert","year":"2017","journal-title":"Molecular Brain"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib71","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphar.2020.00356","article-title":"Modeling parkinson\u2019s disease with the alpha-uclein protein","volume":"11","author":"G\u00f3mez-Benito","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"1807","key":"10.1016\/bs.apcsb.2025.08.012_bib72","first-page":"1205","article-title":"Protein folding and misfolding: A paradigm of self-assembly and regulation in complex biological systems","volume":"361","author":"Gregersen","year":"2005","journal-title":"Philosophical Transactions Series A, Mathematical, Physical, and Engineering Sciences"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib73","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/nu13072411","article-title":"Synergistic neuroprotective effects of a natural product mixture against AD hallmarks and cognitive decline in caenorhabditis elegans and an SAMP8 mice model","volume":"13","author":"Gri\u00f1\u00e1n-Ferr\u00e9","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.012_bib74","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.biocel.2004.04.020","article-title":"Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and \u2019aggresomes\u2019 during oxidative stress, aging, and disease","volume":"36","author":"Grune","year":"2004","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"s1","key":"10.1016\/bs.apcsb.2025.08.012_bib75","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of amyloid-\u03b2 and tau proteins in Alzheimer\u2019s disease: Confuting the amyloid cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct \u03b1-uclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.conb.2021.10.002","article-title":"Alexander disease: Models, mechanisms, and Medicine","volume":"72","author":"Hagemann","year":"2022","journal-title":"Current Opinion in Neurobiology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib78","series-title":"StatPearls [Internet]","article-title":"Lewy body dementia","author":"Haider","year":"2023"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib79","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","article-title":"Control of autophagy as a therapy for neurodegenerative disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nature Reviews Neurology"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.08.012_bib80","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1038\/emboj.2010.225","article-title":"Heat shock factor 1 ameliorates proteotoxicity in cooperation with the transcription factor NFAT","volume":"29","author":"Hayashida","year":"2010","journal-title":"The EMBO Journal"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.012_bib81","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/embor.2013.137","article-title":"Seeded strain-like transmission of \u03b2-amyloid morphotypes in APP transgenic mice","volume":"14","author":"Heilbronner","year":"2013","journal-title":"EMBO Reports"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.012_bib82","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00702-023-02686-7","article-title":"Practical use of apomorphine infusion in Parkinson\u2019s disease: Lessons from the TOLEDO study and clinical experience","volume":"130","author":"Henriksen","year":"2023","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","article-title":"Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of tramiprosate in development for the treatment of Alzheimer\u2019s disease","volume":"57","author":"Hey","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-uclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Molecular Neurodegeneration"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.012_bib85","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","article-title":"Proteostasis impairment in protein-misfolding and -aggregation diseases","volume":"24","author":"Hipp","year":"2014","journal-title":"Trends in Cell Biology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib86","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3892\/etm.2016.3566","article-title":"Huntington\u2019s disease: Molecular basis of pathology and status of current therapeutic approaches","volume":"12","author":"Huang","year":"2016","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib87","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","article-title":"Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy","volume":"33","author":"Iba","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00401-011-0913-0","article-title":"Molecular pathology and genetic advances in amyotrophic lateral sclerosis: An emerging molecular pathway and the significance of glial pathology","volume":"122","author":"Ince","year":"2011","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cell.2013.11.047","article-title":"Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events","volume":"156","author":"Jackrel","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib90","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nsmb.3150","article-title":"Structures of HSF2 reveal mechanisms for differential regulation of human heat-shock factors","volume":"23","author":"Jaeger","year":"2016","journal-title":"Nature Structural & Molecular Biology"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib91","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","article-title":"Exome sequencing reveals VCP mutations as a cause of familial ALS","volume":"68","author":"Johnson","year":"2010","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib92","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib93","first-page":"289","article-title":"Preclinical progression of neurodegenerative diseases","volume":"80","author":"Katsuno","year":"2018","journal-title":"Nagoya Journal of Medical Science"},{"issue":"363","key":"10.1016\/bs.apcsb.2025.08.012_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Science Translational Medicine"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib95","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MS9.0000000000001664","article-title":"Insights into the management of lewy body dementia: A scoping review","volume":"86","author":"Khan","year":"2024","journal-title":"Annals of Medicine and Surgery"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/hmg\/ddv445","article-title":"NEDD4-mediated HSF1 degradation underlies \u03b1-ucleinopathy","volume":"25","author":"Kim","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib97","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/S0006-3495(03)74772-9","article-title":"Competition between protein folding and aggregation with molecular chaperones in crowded solutions: Insight from mesoscopic simulations","volume":"85","author":"Kinjo","year":"2003","journal-title":"Biophysical Journal"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib98","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib99","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.arr.2010.02.001","article-title":"Protein homeostasis and aging: The importance of exquisite quality control","volume":"10","author":"Koga","year":"2011","journal-title":"Ageing Research Reviews"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","article-title":"Adulthood leukodystrophies","volume":"14","author":"K\u00f6hler","year":"2018","journal-title":"Nature Reviews Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib101","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/ncomms2417","article-title":"Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration","volume":"4","author":"Kondo","year":"2013","journal-title":"Nature Communications"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.012_bib102","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation","volume":"10","author":"Kopito","year":"2000","journal-title":"Trends in Cell Biology"},{"issue":"2-3","key":"10.1016\/bs.apcsb.2025.08.012_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(02)01842-3","article-title":"Mitochondria, Ca2+ and neurodegenerative disease","volume":"447","author":"Krieger","year":"2002","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib104","series-title":"StatPearls [Internet]","article-title":"Alexander disease. 2022 sep 5","author":"Kuhn","year":"2023"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib105","first-page":"226","article-title":"Misfolding of proteins in neurodegenerative diseases: Implications and interventions merugumolu Vijay Kumar1","author":"Kumar","year":"2024","journal-title":"Exploring Molecular Targets to Treat Neurodegenerative Disorders"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.012_bib106","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","article-title":"Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of huntington disease","volume":"121","author":"Labbadia","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-060614-033955","article-title":"The biology of proteostasis in aging and disease","volume":"84","author":"Labbadia","year":"2015","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib108","unstructured":"Lamichhane, A., & Rocha Cabrero, F. (2023). Metachromatic Leukodystrophy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan\u2013. PMID: 32809579."},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib109","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acs.biochem.5b01168","article-title":"Stabilization of \u03b1-Synuclein fibril clusters prevents fragmentation and reduces seeding activity and toxicity","volume":"55","author":"Lam","year":"2016","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib110","doi-asserted-by":"crossref","first-page":"R617","DOI":"10.1016\/S0960-9822(06)00316-2","article-title":"Yeast prions: Inheritance by seeded protein polymerization?","volume":"7","author":"Lansbury","year":"1997","journal-title":"Current Biology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib111","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-1-61779-551-0_23","article-title":"Cell-to-cell transmission of \u03b1-uclein aggregates","author":"Lee","year":"2012","journal-title":"Amyloid Proteins: Methods and Protocols"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib112","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1042\/BST20220590","article-title":"Deciphering the mechanism and function of Hsp100 unfoldases from protein structure","volume":"50","author":"Lee","year":"2022","journal-title":"Biochemical Society Transactions"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib113","article-title":"Facilitated tau degradation by USP14 aptamers via enhanced proteasome activity","volume":"5","author":"Lee","year":"2015","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib114","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib236","first-page":"712","article-title":"Huntington\u2019s disease protein extends its reach","volume":"181","author":"Leslie","year":"2008","journal-title":"Journal of Cell Biology"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1534-5807(04)00099-1","article-title":"Development by self-digestion: Molecular mechanisms and biological functions of autophagy","volume":"6","author":"Levine","year":"2004","journal-title":"Developmental Cell"},{"issue":"41","key":"10.1016\/bs.apcsb.2025.08.012_bib116","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1523\/JNEUROSCI.2600-15.2015","article-title":"Chaperones in neurodegeneration","volume":"35","author":"Lindberg","year":"2015","journal-title":"The Journal of Neuroscience: the Official Journal of the Society for Neuroscience"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib117","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.biocel.2011.01.022","article-title":"Heat shock protein 104 inhibited the fibrillization of prion peptide 106\u2013126 and disassembled prion peptide 106\u2013126 fibrils in vitro","volume":"43","author":"Liu","year":"2011","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib118","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2019.03.043","article-title":"Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced parkinson disease in mice","volume":"367","author":"Liu","year":"2019","journal-title":"Behavioural Brain Research"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib119","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/brain\/awac202","article-title":"Seeding, maturation and propagation of amyloid \u03b2-peptide aggregates in Alzheimer\u2019s disease","volume":"145","author":"Li","year":"2022","journal-title":"Brain"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib120","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.012_bib121","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1007\/s00415-023-11791-2","article-title":"The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: A systematic review and meta-analysis","volume":"270","author":"Lyons","year":"2023","journal-title":"Journal of Neurology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib122","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fmolb.2016.00008","article-title":"Engineering and evolution of molecular chaperones and protein disaggregases with enhanced activity","volume":"3","author":"Mack","year":"2016","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib123","doi-asserted-by":"crossref","DOI":"10.1038\/srep35106","article-title":"mTOR independent regulation of macroautophagy by leucine rich repeat kinase 2 via Beclin-1","volume":"6","author":"Manzoni","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib124","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-2404-2_3","article-title":"Autophagy and aging","volume":"847","author":"Martinez-Lopez","year":"2015","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib125","first-page":"115","article-title":"Autophagy in neurodegenerative diseases: From pathogenic dysfunction to therapeutic modulation","volume":"2015","author":"Martinez-Vicente","year":"2015"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib126","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acschembio.6b00223","article-title":"Inhibition of both Hsp70 activity and tau aggregation in vitro best predicts tau lowering activity of small molecules","volume":"11","author":"Martin","year":"2016","journal-title":"ACS Chemical Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib127","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/agm2.12243","article-title":"Neurodegenerative disorders: Assessing the impact of natural vs drug\u2010induced treatment options","volume":"6","author":"Mathur","year":"2023","journal-title":"Aging Medicine"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib129","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3233\/JPD-199002","article-title":"Clinical trial highlights\u2013dyskinesia","volume":"9","author":"McFarthing","year":"2019","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2004.6.3\/imckeith","article-title":"Dementia with lewy bodies","volume":"6","author":"McKeith","year":"2004","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.012_bib131","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1089\/ars.2013.5802","article-title":"The ubiquitin-proteasome system in neurodegeneration","volume":"21","author":"McKinnon","year":"2014","journal-title":"Antioxidants & Redox Signaling"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.012_bib132","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/mds.29228","article-title":"Prevalence and incidence of Huntington\u2019s disease: An updated systematic review and meta-analysis","volume":"37","author":"Medina","year":"2022","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1196413","article-title":"Alzheimer\u2019s disease and neuroinflammation: Will new drugs in clinical trials pave the way to a multi-target therapy?","volume":"14","author":"Melchiorri","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib134","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","article-title":"HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers","volume":"150","author":"Mendillo","year":"2012","journal-title":"Cell"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.012_bib135","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/ddi312","article-title":"Endoplasmic reticulum stress compromises the ubiquitin-proteasome system","volume":"14","author":"Men\u00e9ndez-Benito","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2010.05.013","article-title":"Strategies for treatment in Alexander disease","volume":"7","author":"Messing","year":"2010","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental Neuro Therapeutics"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib137","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1381612822666161206141744","article-title":"Neurodegenerative disease: A perspective on cell-based therapy in the new era of cell-free nano-therapy","volume":"23","author":"Metcalfe","year":"2017","journal-title":"Current Pharmaceutical Design"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib138","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nm.3951","article-title":"Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits","volume":"21","author":"Min","year":"2015","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib139","doi-asserted-by":"crossref","first-page":"23","DOI":"10.32345\/USMYJ.2(146).2024.23-30","article-title":"A family case of hereditary olivopontocerebellar atrophy: features of diagnosis and course of the disease","volume":"146","author":"Mishura","year":"2024","journal-title":"The Ukrainian Scientific Medical Youth Journal"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib140","first-page":"482","article-title":"Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission","volume":"2011","author":"Moreno-Gonzalez","year":"2011"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib141","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-008-0396-9","article-title":"Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia","volume":"116","author":"Mori","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib142","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1038\/ncomms7609","article-title":"The Parkinson\u2019s-associated protein DJ-1 regulates the 20S proteasome","volume":"6","author":"Moscovitz","year":"2015","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib143","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","article-title":"Modulation of neurodegeneration by molecular chaperones","volume":"6","author":"Muchowski","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib144","unstructured":"Muengtaweepongsa, S,. & Lolekha, P. (2018). Olivopontocerebellar Atrophy.Medscape."},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","article-title":"Recent advances in drug therapy for Parkinson\u2019s disease","volume":"62","author":"Murakami","year":"2023","journal-title":"Internal Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib146","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","article-title":"Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling","volume":"22","author":"Myeku","year":"2016","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/bs.apcsb.2025.08.012_bib147","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrd3453","article-title":"Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases","volume":"10","author":"Neef","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6079","key":"10.1016\/bs.apcsb.2025.08.012_bib148","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.1214203","article-title":"Structure of an intermediate state in protein folding and aggregation","volume":"336","author":"Neudecker","year":"2012","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","article-title":"Frontotemporal dementia","volume":"35","author":"Olney","year":"2017","journal-title":"Neurologic Clinics"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib151","first-page":"337","article-title":"The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases","volume":"34","author":"Opattova","year":"2015","journal-title":"General Physiology and Biophysics"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib152","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with lewy bodies: An update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib153","first-page":"1","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","author":"Pagano","year":"2024","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib154","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2017.10.007","article-title":"Diagnosis of multiple system atrophy","volume":"211","author":"Palma","year":"2018","journal-title":"Autonomic Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib155","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s12041-018-0957-1","article-title":"Huntington\u2019s disease: The coming of age","volume":"97","author":"Pandey","year":"2018","journal-title":"Journal of Genetics"},{"issue":"20","key":"10.1016\/bs.apcsb.2025.08.012_bib156","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of \u03b1-uclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"Journal of Neuroscience"},{"issue":"48","key":"10.1016\/bs.apcsb.2025.08.012_bib157","doi-asserted-by":"crossref","first-page":"47449","DOI":"10.1074\/jbc.M309514200","article-title":"Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency","volume":"278","author":"Pedersen","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib158","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib159","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","article-title":"Multiple system atrophy","volume":"8","author":"Poewe","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev-pharmtox-010814-124332","article-title":"Targeting proteostasis through the protein quality control function of the Hsp90\/Hsp70-based chaperone machinery for treatment of adult onset neurodegenerative diseases","volume":"55","author":"Pratt","year":"2014","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib161","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuint.2017.01.016","article-title":"Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington\u2019s disease?","volume":"106","author":"Precious","year":"2017","journal-title":"Neurochemistry International"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/srep14809","article-title":"SDS-PAGE analysis of A\u03b2 oligomers is disserving research into Alzheimer\u00b4s disease: Appealing for ESI-IM-MS","volume":"5","author":"Pujol-Pina","year":"2015","journal-title":"Scientific Reports"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib164","article-title":"Ubiquitin-proteasome system in neurodegenerative disorders","volume":"6","author":"Rao","year":"2015","journal-title":"Journal of Drug Metabolism & Toxicology"},{"issue":"11","key":"10.1016\/bs.apcsb.2025.08.012_bib165","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence of frontotemporal dementia","volume":"58","author":"Ratnavalli","year":"2002","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib166","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/bs.apcsb.2025.08.012_bib167","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/01.wnl.0000260965.20021.47","article-title":"Focality of upper and lower motor neuron degeneration at the clinical onset of ALS","volume":"68","author":"Ravits","year":"2007","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/bs.apcsb.2025.08.012_bib168","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib169","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s000180300028","article-title":"Stress proteins in neural cells: Functional roles in health and disease","volume":"60","author":"Richter-Landsberg","year":"2003","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib171","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrneurol.2016.5","article-title":"Targeting tauopathies for therapeutic translation","volume":"12","author":"Rojas","year":"2016","journal-title":"Nature Reviews Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib172","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib173","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ana.26073","article-title":"Foslevodopa\/foscarbidopa: A new subcutaneous treatment for Parkinson\u2019s disease","volume":"90","author":"Rosebraugh","year":"2021","journal-title":"Annals of Neurology"},{"issue":"7615","key":"10.1016\/bs.apcsb.2025.08.012_bib174","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature18943","article-title":"An evolutionarily conserved pathway controls proteasome homeostasis","volume":"536","author":"Rousseau","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","article-title":"Targeting human central nervous system protein kinases: An isoform selective p38\u03b1MAPK inhibitor that attenuates disease progression in Alzheimer\u2019s disease mouse models","volume":"6","author":"Roy","year":"2015","journal-title":"ACS Chemical Neuroscience"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib176","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2015.04.013","article-title":"Widespread macromolecular interaction perturbations in human genetic disorders","volume":"161","author":"Sahni","year":"2015","journal-title":"Cell"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib177","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","article-title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies","volume":"82","author":"Sanders","year":"2014","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib178","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1074\/jbc.M114.606293","article-title":"Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy","volume":"290","author":"Sasazawa","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.012_bib179","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1523\/JNEUROSCI.1675-13.2014","article-title":"A sensitive a\u03b2 oligomer assay discriminates Alzheimer\u2019s and aged control cerebrospinal fluid","volume":"34","author":"Savage","year":"2014","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/9781119251316.ch29","article-title":"Wilson disease","author":"Schilsky","year":"2017","journal-title":"Schiff\u2019s Diseases of the Liver"},{"issue":"3","key":"10.1016\/bs.apcsb.2025.08.012_bib181","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI200317741","article-title":"Neuronal degeneration and mitochondrial dysfunction","volume":"111","author":"Schon","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib182","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schr\u00f6der","year":"2005","journal-title":"Annual Review of Biochemistry"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.012_bib183","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types a and b Niemann-pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib184","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","article-title":"Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases","volume":"29","author":"Sherman","year":"2001","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clinics in Geriatric Medicine"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib187","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/ijerph19010364","article-title":"Systematic review on Parkinson\u2019s disease medications, emphasizing on three recently approved drugs to control Parkinson\u2019s symptoms","volume":"19","author":"Sivanandy","year":"2021","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"1-2","key":"10.1016\/bs.apcsb.2025.08.012_bib188","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1023\/B:MCBI.0000009880.94044.49","article-title":"Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis","volume":"256-257","author":"Skulachev","year":"2004","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib189","first-page":"142","article-title":"Molecular chaperones and neuronal proteostasis","volume":"2015","author":"Smith","year":"2015"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ceb.2013.12.006","article-title":"Sorting out the trash: The spatial nature of eukaryotic protein quality control","volume":"26","author":"Sontag","year":"2014","journal-title":"Current Opinion in Cell Biology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib191","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0531-5565(03)00185-2","article-title":"Aging and molecular chaperones","volume":"38","author":"Soti","year":"2003","journal-title":"Experimental Gerontology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib192","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib193","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbadis.2004.08.004","article-title":"Protein misfolding and aggregation: New examples in medicine and biology of the dark side of the protein world","volume":"1739","author":"Stefani","year":"2004","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib194","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00441-018-2814-1","article-title":"The concept of alpha-uclein as a prion-like protein: Ten years after","volume":"373","author":"Steiner","year":"2018","journal-title":"Cell and Tissue Research"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mdc3.13489","article-title":"Systematic review of prevalence studies of progressive supranuclear palsy and corticobasal syndrome","volume":"9","author":"Swallow","year":"2022","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib196","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: Implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: Implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib198","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","article-title":"Huntingtin lowering strategies for disease modification in Huntington\u2019s disease","volume":"101","author":"Tabrizi","year":"2019","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib199","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.21080800","article-title":"Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: A randomized double-blind controlled trial","volume":"179","author":"Tabuteau","year":"2022","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib200","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/978-1-4614-0653-2_23","article-title":"Pick\u2019s disease","author":"Takeda","year":"2012","journal-title":"Neurodegenerative Diseases"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib201","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00415-022-11467-3","article-title":"Sporadic Creutzfeldt\u2013Jakob disease in the young (50 and below): 10-year review of United Kingdom surveillance","volume":"270","author":"Tam","year":"2023","journal-title":"Journal of Neurology"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013675","article-title":"Analysis of chaperone mRNA expression in the adult mouse brain by meta analysis of the allen brain Atlas","volume":"5","author":"Tebbenkamp","year":"2010","journal-title":"PloS ONE"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.phrs.2015.12.028","article-title":"Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain","volume":"104","author":"Thirstrup","year":"2016","journal-title":"Pharmacological Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2008.03.002","article-title":"Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25\u201335)","volume":"190","author":"Tsunekawa","year":"2008","journal-title":"Behavioural Brain Research"},{"issue":"4","key":"10.1016\/bs.apcsb.2025.08.012_bib205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: A product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"Progress in Lipid Research"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib206","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(19)30615-2","article-title":"Creutzfeldt-Jakob disease: A systematic review of global incidence, prevalence, infectivity, and incubation","volume":"20","author":"Uttley","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib207","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-uclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib162","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.parkreldis.2021.10.023","article-title":"Spinocerebellar ataxias in Asia: Prevalence, phenotypes and management","volume":"92","author":"van Prooije","year":"2021","journal-title":"Parkinsonism & Related Disorders"},{"issue":"s1","key":"10.1016\/bs.apcsb.2025.08.012_bib216","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.3233\/JPD-181476","article-title":"Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson\u2019s disease","volume":"8","author":"Van Wamelen","year":"2018","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib208","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.drudis.2015.09.004","article-title":"Challenges and opportunities for non-antibody scaffold drugs","volume":"20","author":"Vazquez-Lombardi","year":"2015","journal-title":"Drug Discovery Today"},{"issue":"1807","key":"10.1016\/bs.apcsb.2025.08.012_bib209","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1098\/rsta.2003.1194","article-title":"Protein folding and misfolding: A paradigm of self-assembly and regulation in complex biological systems","volume":"361","author":"Vendruscolo","year":"2003","journal-title":"Philosophical transactions Series A, Mathematical, Physical, and Engineering Sciences"},{"issue":"5","key":"10.1016\/bs.apcsb.2025.08.012_bib210","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1523\/JNEUROSCI.3039-13.2014","article-title":"HSF1 protects neurons through a novel trimerization-and HSP-independent mechanism","volume":"34","author":"Verma","year":"2014","journal-title":"Journal of Neuroscience"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib211","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/hmg\/dds040","article-title":"Targeting the UPR transcription factor XBP1 protects against Huntington\u2019s disease through the regulation of FoxO1 and autophagy","volume":"21","author":"Vidal","year":"2012","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib212","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-1-2","article-title":"The prion hypothesis in Parkinson\u2019s disease: Braak to the future","volume":"1","author":"Visanji","year":"2013","journal-title":"Acta Neuropathologica Communications"},{"issue":"10107","key":"10.1016\/bs.apcsb.2025.08.012_bib57","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","article-title":"Amyotrophic lateral sclerosis","volume":"390","author":"van Es","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"13","key":"10.1016\/bs.apcsb.2025.08.012_bib214","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1074\/jbc.M114.627463","article-title":"Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease","volume":"290","author":"Wadhwa","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"9557","key":"10.1016\/bs.apcsb.2025.08.012_bib215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"The Lancet"},{"issue":"18","key":"10.1016\/bs.apcsb.2025.08.012_bib217","doi-asserted-by":"crossref","first-page":"13927","DOI":"10.3390\/ijms241813927","article-title":"Simufilam reverses aberrant receptor interactions of filamin a in Alzheimer\u2019s disease","volume":"24","author":"Wang","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib218","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/mp.2016.104","article-title":"A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer\u2019s mouse model via an HSF1-mediated mechanism","volume":"22","author":"Wang","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"Pt 18","key":"10.1016\/bs.apcsb.2025.08.012_bib219","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1242\/jeb.01022","article-title":"Oxidants, antioxidants and the ischemic brain","volume":"207","author":"Warner","year":"2004","journal-title":"The Journal of Experimental Biology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-014-1290-2","article-title":"Do current therapeutic anti-A\u03b2 antibodies for Alzheimer\u2019s disease engage the target?","volume":"127","author":"Watt","year":"2014","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.apcsb.2025.08.012_bib221","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7601930","article-title":"The two faces of protein misfolding: Gain\u2010and loss\u2010of\u2010function in neurodegenerative diseases","volume":"27","author":"Winklhofer","year":"2008","journal-title":"The EMBO Journal"},{"issue":"8","key":"10.1016\/bs.apcsb.2025.08.012_bib222","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tibs.2005.06.001","article-title":"Oxidative activation of antioxidant defence","volume":"30","author":"Winyard","year":"2005","journal-title":"Trends in Biochemical Sciences"},{"issue":"6","key":"10.1016\/bs.apcsb.2025.08.012_bib223","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.neuron.2014.12.064","article-title":"Immunotherapeutic approaches for Alzheimer\u2019s disease","volume":"85","author":"Wisniewski","year":"2015","journal-title":"Neuron"},{"issue":"6269","key":"10.1016\/bs.apcsb.2025.08.012_bib224","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.aad2033","article-title":"Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA","volume":"351","author":"Woerner","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"10","key":"10.1016\/bs.apcsb.2025.08.012_bib225","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nchembio.635","article-title":"Ligand binding to distinct states diverts aggregation of an amyloid-forming protein","volume":"7","author":"Woods","year":"2011","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-319-57193-5_4","article-title":"Huntington\u2019s disease: Pathogenic mechanisms and therapeutic targets","author":"Wright","year":"2017","journal-title":"Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib227","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-319-57193-5_4","article-title":"Huntington\u2019s disease: Pathogenic mechanisms and therapeutic targets","volume":"15","author":"Wright","year":"2017","journal-title":"Advances in Neurobiology"},{"issue":"7","key":"10.1016\/bs.apcsb.2025.08.012_bib228","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease","volume":"127","author":"Yang","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/bs.apcsb.2025.08.012_bib229","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-007-0285-7","article-title":"TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia","volume":"115","author":"Zhang","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.012_bib230","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and tau in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Zhang","year":"2021","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib231","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/NDT.S179453","article-title":"The efficacy of a \u201ccocktail therapy\u201d on Parkinson\u2019s disease with dementia","author":"Zhang","year":"2019","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"17","key":"10.1016\/bs.apcsb.2025.08.012_bib232","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1093\/emboj\/cdf445","article-title":"A mitochondrial specific stress response in mammalian cells","volume":"21","author":"Zhao","year":"2002","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib233","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fnmol.2018.00329","article-title":"A mitochondria-associated oxidative stress perspective on Huntington\u2019s disease","volume":"11","author":"Zheng","year":"2018","journal-title":"Frontiers in Molecular Neuroscience"},{"issue":"9","key":"10.1016\/bs.apcsb.2025.08.012_bib234","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/hmg\/ddy061","article-title":"Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington\u2019s disease","volume":"27","author":"Zhou","year":"2018","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2025.08.012_bib235","unstructured":"Zilganersen. (2024). Sodium by Ionis pharmaceuticals for Alexander disease: Likelihood of approval. Available from: https:\/\/www.pharmaceutical-technology.com\/data-insights\/zilganersen-sodium-ionispharmaceuticals-alexander-disease-likelihood-of-approval\/?cf-view."},{"key":"10.1016\/bs.apcsb.2025.08.012_fur1","doi-asserted-by":"crossref","unstructured":"Pocchiari, M., & Manson, J. (2018). Dominantly inherited prion protein cerebral amyloidoses\u2013a modern view of Gerstmann\u2013Straussler\u2013Scheinker. Human Prion Diseases, 243.","DOI":"10.1016\/B978-0-444-63945-5.00014-3"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Protein Misfolding Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162325000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:59:11Z","timestamp":1766156351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162325000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443294143"],"references-count":237,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2025.08.012","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}